cervical carcinoma
Conditions
Interventions
treatment group:Nedaplatin
Sponsors
Affiliated Hospital of Luzhou Medical College
Eligibility
Sex/Gender
Female
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with the pathological diagnosis of cervical cancer; 2. Patients of cervical cancer stage IIb - IVa (according to 2009, FIGO); 3. 20 to 70 years old; 4. Karnofsky score >=70, with weight loss =4.0*10^9/L, neutrophils >=1.5*10^9/L, the PLT >=100*10^9/L, HGB>100g/L; 6. Normal liver and kidney function; 7. Not suffering from other primary cancer and no radiotherapy and chemotherapy in 5 years; 8. No distant metastasis by examination of MRI, CT, chest X-ray and B ultrasonic imaging; 9. No other serious comorbidities such as hypertension, tuberculosis and type 2 diabetes, etc; 10. Not in pregnancy or lactation.
Exclusion criteria
Exclusion criteria: (1) The patients ask to quit; (2) The course of treatment is extended for more than one week by other reasons; (3) Adverse reactions beyond the dose-limited toxicity, can not be reversed by symptomatic treatment; (4) Patients combined with neuropsychiatric diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse Events;dose-limiting toxity;curative effect; | — |
Countries
China
Contacts
Public ContactYang hong-ru
Outcome results
None listed